Allergy Therapeutics plc – Positive new data with house-dust mite immunotherapy – Nasdaq
Business Wire (press release) |
Allergy Therapeutics plc – Positive new data with house-dust mite immunotherapy
Nasdaq House-dust mite immunotherapy shown to be well-tolerated and demonstrates highly significant symptom improvement ~. ~ Allergy experts present an overview of adjuvants at satellite symposium during EAACI 2018 ~. 29 May 2018Allergy Therapeutics plc … Aimmune Therapeutics Announces Data on Terminology Used with Oral Immunotherapy Were Presented at EAACI 2018 Allergy Therapeutics announces positive new clinic data with house-dust mite immunotherapy Allergy Therapeutics Plc Positive new clinical data with house-dust mite immunotherapy |
